Compartment-specific PPARδ activity controls the outcome of cancer-immune cell competition and immunotherapy efficacy.

作者信息Paul Bunk, Ilgin Ergin, Timothy Maher, Vyom Shah, Julia R Bonney, Lokesh B S S Kumar, Charlie Chung, Nils Wellhausen, Philip Moresco, Sarah Shao, Jill Habel, Vinay Mandati, Rachel Rubino, David E Rivadeneira, John E Wilkinson, Laura Herrero, Peter M K Westcott, Samuel E Weinberg, Saar I Gill, Nathalie Y R Agar, Semir Beyaz
PMID42875546
发布时间2026-11
DOI10.1038/s41590-026-02685-2

摘要

Most patients with solid tumors fail to sustain antitumor immunity, in part because immune cells cannot outcompete cancer cells inside the immunosuppressive tumor microenvironment. Here, we show the lipid-sensing transcription factor PPARδ is a compartment-specific determinant of cancer-immune fitness balance and immunotherapy efficacy. Activating PPARδ in cancer cells promotes their growth and impairs antitumor immunity, whereas activating it in immune cells drives tumor suppression and overrides tumor-promoting effects of cancer-intrinsic activation. Mechanistically, PPARδ enhances CD8+ T cell fitness against cancer through effector-associated chromatin remodeling and Cpt1a-mediated fatty acid oxidation. Therapeutically, PPARδ-activated CD8+ T cells sensitize immunotherapy-resistant microsatellite stable metastatic colorectal cancer to checkpoint blockade in mice, and pharmacological or genetic PPARδ activation enhances human chimeric antigen receptor T cell function. These findings identify compartment-specific PPARδ activity as a targetable driver of immune cell fitness that can be harnessed to improve outcomes in immunotherapy-resistant tumors.